APA (7th ed.) Citation

ES, B., R, O., N, S., KE, J., M, A., C, S., . . . S, P. (2026). Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist. The Journal of pharmacology and experimental therapeutics, 393(6), 104932. https://doi.org/10.1016/j.jpet.2026.104932

Chicago Style (17th ed.) Citation

ES, Burstein, et al. "Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist." The Journal of Pharmacology and Experimental Therapeutics 393, no. 6 (2026): 104932. https://doi.org/10.1016/j.jpet.2026.104932.

MLA (9th ed.) Citation

ES, Burstein, et al. "Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist." The Journal of Pharmacology and Experimental Therapeutics, vol. 393, no. 6, 2026, p. 104932, https://doi.org/10.1016/j.jpet.2026.104932.